This peptide can improve collagen synthesis and elastin formation, improving skin elasticity, skin texture and sensitive skin, reducing the primary causes of skin aging
Mitochondrial control of inflammation
503A compounding is subject to state pharmacy board oversight and USP sterility standards for injectable preparations, but it is not subject to the FDA's drug approval process, pre-market review, or post-market surveillance requirements that apply to branded pharmaceutical products
Topical prescription agents such as hydroquinone, retinoids, azelaic acid, or tranexamic acid are applied directly to affected areas and are used under medical supervision to influence pigment production and skin renewal processes
If you have not seen meaningful changes after three months of consistent use, the product is likely not going to suddenly start working